US Patent 7919461 Erythropoietin receptor peptide formulations and uses
Patent 7919461 was granted and assigned to Affymax, Inc. on April, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7919461 Erythropoietin receptor peptide formulations and uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.